PNPaola Negovetić

Paola Negovetić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paola Negovetić has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cytokine Profiling in Cutaneous Melanoma: The Emerging Role of Interleukins in Prognostic Stratification with an Up-to-Date Overview of Published Data

    by Paola Negovetić, Klara Gaćina, Nika Franceschi, Marija Buljan

    Background: Cutaneous melanoma is an aggressive malignancy driven by complex interactions between tumor cells and the host immune system. Tumor progression is shaped not only by intrinsic tumor characteristics but also by immune-mediated processes within the tumor microenvironment. Cytokines, particularly interleukins, are key regulators of inflammation, immune cell recruitment, and tumor behavior. Cytokine profiling provides an integrated assessment of soluble immune mediators from tumor and stromal cells, reflecting both local and systemic immune responses. Methods: This narrative review summarizes and synthesizes the current literature addressing the biological and clinical relevance of selected interleukins, including IL-6, IL-8, IL-10, IL-2, IL-17, and IL-18, in cutaneous melanoma. Published data were evaluated with a focus on their immunomodulatory functions and potential implications for prognostic assessment. Results: Interleukins demonstrated distinct and context-dependent prognostic and predictive relevance in cutaneous melanoma. Elevated IL-2 levels correlated with sentinel lymph node positivity, supporting its prognostic value in early disease. Increased circulating IL-6 and IL-8 were consistently associated with tumor burden, advanced disease, and reduced survival. IL-10 expression reflected tumor progression and immune modulation. IL-17 signatures predicted response to combined immune checkpoint inhibition, particularly in BRAFV600-mutant melanoma. IL-18 exhibited dual roles, associating with both immune activation and favorable outcomes depending on tumor context. Conclusions: Interleukin profiling offers a biologically relevant framework for understanding immune regulation in cutaneous melanoma. Integrating interleukin signatures into prognostic models may support more refined risk stratification and advance the implementation of personalized medicine approaches in melanoma management.


  • Open Access

    Dermoscopy of Facial Dermatoses: An Updated Review

    by Nika Filipović Mioč, Paola Negovetić, Klara Gaćina, Marija Buljan

    Dermoscopy is an essential, non-invasive diagnostic tool that has transformed the evaluation of pigmented skin lesions and is nowadays also increasingly recognized for its utility in general dermatology. Originally developed for the early detection of melanoma, dermoscopy now aids in diagnosing a wide range of non-neoplastic skin disorders—including inflammatory, infectious, and infiltrative conditions—by revealing morphological features invisible to the naked eye. Among these, facial dermatoses represent a diagnostically challenging group of disorders with overlapping clinical presentations. This review provides a comprehensive overview of the latest literature on dermoscopy in general dermatology, with a specific focus on facial dermatoses. Relevant information for this article was obtained through a comprehensive PubMed search using disease names along with the terms ‘dermoscopy’ and ‘dermatoscopy’. Despite its growing relevance, this field remains underexplored, largely due to the lack of standardized dermoscopic criteria and inconsistent terminology, which pose challenges to broader clinical implementation. Nonetheless, current evidence highlights the promising role played by dermoscopy as an adjunctive diagnostic method, particularly when used by experienced clinicians in combination with detailed patient history and clinical examination. Dermoscopy of facial dermatoses has the potential to significantly improve diagnostic precision in everyday practice. With continued research, greater standardization, and wider clinician training, dermoscopy is well-positioned to become as integral to the diagnosis of inflammatory and infectious dermatoses as it is to skin cancer detection.

  • Open Access

    Dermoscopy of Facial Dermatoses: An Updated Review

    by Nika Filipović Mioč, Paola Negovetic, Klara Gaćina, Marija Buljan

    Dermoscopy is an essential, non-invasive diagnostic tool that has transformed the evaluation of pigmented skin lesions and is nowadays also increasingly recognized for its utility in general dermatology. Originally developed for the early detection of melanoma, dermoscopy now aids in diagnosing a wide range of non-neoplastic skin disorders—including inflammatory, infectious, and infiltrative conditions—by revealing morphological features invisible to the naked eye. Among these, facial dermatoses represent a diagnostically challenging group of disorders with overlapping clinical presentations. This review provides a comprehensive overview of the latest literature on dermoscopy in general dermatology, with a specific focus on facial dermatoses. Relevant information for this article was obtained through a comprehensive PubMed search using disease names along with the terms 'dermoscopy' and 'dermatoscopy.' Despite its growing relevance, this field remains underexplored, largely due to the lack of standardized dermoscopic criteria and inconsistent terminology, which pose challenges to broader clinical implementation. Nonetheless, current evidence highlights the promising role of dermoscopy as an adjunctive diagnostic method, particularly when used by experienced clinicians in combination with detailed patient history and clinical examination. Dermoscopy of facial dermatoses has the potential to significantly improve diagnostic precision in everyday practice. With continued research, greater standardization, and wider clinician training, dermoscopy is well-positioned to become as integral to the diagnosis of inflammatory and infectious dermatoses as it is to skin cancer detection.